본문으로 건너뛰기
← 뒤로

Prognostic value of positron emission tomography/computed tomography metabolic parameters in assessing primary gastrointestinal diffuse large B-cell lymphoma.

1/5 보강
Nuclear medicine communications 📖 저널 OA 13.8% 2026
Retraction 확인
출처

PICO 자동 추출 (휴리스틱, conf 2/4)

유사 논문
P · Population 대상 환자/모집단
환자: primary gastrointestinal diffuse large B-cell lymphoma (PGI-DLBCL)
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
[CONCLUSION] MTV, △SUVmax, TLG, and △MTV are effective for evaluating for mid-term remission in PGI-DLBCL patients. Among them, MTV and △SUVmax serve as independent prognostic factors.

Lin F, Yu L, Cai L, Wu P

📝 환자 설명용 한 줄

[PURPOSE] This study aimed to evaluate the prognostic significance of fluorine-18 (18F) fluorodeoxyglucose PET/computed tomography (CT) metabolic parameters in patients with primary gastrointestinal d

🔬 핵심 임상 통계 (초록에서 자동 추출 — 원문 검증 권장)
  • p-value P < 0.05

이 논문을 인용하기

↓ .bib ↓ .ris
APA Lin F, Yu L, et al. (2026). Prognostic value of positron emission tomography/computed tomography metabolic parameters in assessing primary gastrointestinal diffuse large B-cell lymphoma.. Nuclear medicine communications. https://doi.org/10.1097/MNM.0000000000002143
MLA Lin F, et al.. "Prognostic value of positron emission tomography/computed tomography metabolic parameters in assessing primary gastrointestinal diffuse large B-cell lymphoma.." Nuclear medicine communications, 2026.
PMID 41913667

Abstract

[PURPOSE] This study aimed to evaluate the prognostic significance of fluorine-18 (18F) fluorodeoxyglucose PET/computed tomography (CT) metabolic parameters in patients with primary gastrointestinal diffuse large B-cell lymphoma (PGI-DLBCL).

[METHODS] We retrospectively analyzed 24 PGI-DLBCL patients treated with R-CHOP chemotherapy. Continuous variables were dichotomized at the median and compared using the t-test, whereas categorical variables [e.g. gender, cell origin (germinal center B-cell/non-germinal center B-cell)] were compared using the Chi-square test. Spearman correlation analysis was performed to examine relationships between metabolic parameters and potential prognostic factors. Univariate Kaplan-Meier survival analysis and multivariate Cox regression were used to identify independent prognostic factors for progression-free survival and overall survival. Prognostic differences among risk groups were also assessed.

[RESULTS] Total lesion glycolysis (TLG), lactate dehydrogenase, International Prognostic Index (IPI), National Comprehensive Cancer Network-IPI, metabolic tumor volume (△MTV, representing changes in MTV between baseline and interim PET/CT), and clinical staging differed significantly between high and low-MTV groups (all P < 0.05).TLG, △MTV, lactate dehydrogenase, IPI score, National Comprehensive Cancer Network-IPI score, and clinical stage were significantly correlated with MTV (all P < 0.05). Receiver operating characteristic analysis indicated that MTV, standardized uptake value (△SUVmax, changes in SUVmax between baseline and interim PET/CT), TLG, and ΔMTV effectively predicted mid-term remission. Multivariate analysis identified MTV and ΔSUVmax as independent predictors of progression-free survival (P < 0.05), whereas ΔSUVmax was independently associated with overall survival (P < 0.05). Cox regression analysis revealed significant prognostic differences among subgroups (P < 0.0001).

[CONCLUSION] MTV, △SUVmax, TLG, and △MTV are effective for evaluating for mid-term remission in PGI-DLBCL patients. Among them, MTV and △SUVmax serve as independent prognostic factors.

🏷️ 키워드 / MeSH

같은 제1저자의 인용 많은 논문 (5)